|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0016030,
umls-concept:C0031727,
umls-concept:C0040691,
umls-concept:C0292688,
umls-concept:C0332307,
umls-concept:C0332461,
umls-concept:C0597357,
umls-concept:C0871261,
umls-concept:C1336624,
umls-concept:C1441547,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1999216,
umls-concept:C2911692
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-10-29
|
|
pubmed:abstractText |
Transforming growth factor-?1 (TGF-?1) has been identified as an important fibrogenic cytokine associated with Peyronie's disease (PD).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth...,
http://linkedlifedata.com/resource/pubmed/chemical/SMAD2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/SMAD3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Smad2 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Smad3 Protein,
http://linkedlifedata.com/resource/pubmed/chemical/TGF-beta type I receptor,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1743-6109
|
|
pubmed:author |
pubmed-author:ChoiMin JiMJ,
pubmed-author:HanJee-YoungJY,
pubmed-author:JinHai-RongHR,
pubmed-author:KimSeong-JinSJ,
pubmed-author:KimWoo JeanWJ,
pubmed-author:KwonMi-HyeMH,
pubmed-author:LeeSang-JinSJ,
pubmed-author:PiaoShuguangS,
pubmed-author:RyuJi-KanJK,
pubmed-author:ShinSun HwaSH,
pubmed-author:SongJae SookJS,
pubmed-author:SuhJun-KyuJK,
pubmed-author:TumurbaatarMunkhbayarM,
pubmed-author:TuvshinturBuyankhuuB,
pubmed-author:YinGuo NanGN
|
|
pubmed:copyrightInfo |
© 2010 International Society for Sexual Medicine.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
7
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3385-95
|
|
pubmed:meshHeading |
pubmed-meshheading:20233292-Active Transport, Cell Nucleus,
pubmed-meshheading:20233292-Adult,
pubmed-meshheading:20233292-Aged,
pubmed-meshheading:20233292-Blotting, Western,
pubmed-meshheading:20233292-Cells, Cultured,
pubmed-meshheading:20233292-Extracellular Matrix,
pubmed-meshheading:20233292-Fibroblasts,
pubmed-meshheading:20233292-Humans,
pubmed-meshheading:20233292-Male,
pubmed-meshheading:20233292-Middle Aged,
pubmed-meshheading:20233292-Penile Induration,
pubmed-meshheading:20233292-Penis,
pubmed-meshheading:20233292-Phosphorylation,
pubmed-meshheading:20233292-Protein-Serine-Threonine Kinases,
pubmed-meshheading:20233292-Receptors, Transforming Growth Factor beta,
pubmed-meshheading:20233292-Smad2 Protein,
pubmed-meshheading:20233292-Smad3 Protein,
pubmed-meshheading:20233292-Transforming Growth Factor beta1
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Transforming growth factor (TGF)-? type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-?1 responses in fibroblasts derived from Peyronie's plaque.
|
|
pubmed:affiliation |
Laboratory of Regenerative Sexual Medicine and Department of Urology, Inha University School of Medicine, Incheon, South Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
